What is the current valuation of the UK viral clearance market?

The market valuation was $44.0 Million in 2024. Read More

What is the projected market size for the UK viral clearance market by 2035?

The market is expected to reach $392.18 Million by 2035. Read More

What is the expected CAGR for the UK viral clearance market during the forecast period 2025 - 2035?

The expected CAGR is 22.0% during the forecast period. Read More

What are the main methods used in the UK viral clearance market?

The main methods include Viral Removal, Viral Inactivation, and Viral Detection. Read More

How much revenue did the Viral Inactivation Method generate in 2024?

The Viral Inactivation Method generated $180.0 Million in 2024. Read More

What was the revenue from Blood and Blood Products in 2024?

Blood and Blood Products generated $90.0 Million in 2024. Read More

What was the revenue generated by the Pharmaceutical and Biotech Industry in 2024?

The Pharmaceutical and Biotech Industry generated $176.09 Million in 2024. Read More

UK Viral Clearance Market

Q: Which companies are considered key players in the UK viral clearance market?

Key players include Sartorius, Merck KGaA, Thermo Fisher Scientific, and others. Read More

Q: What applications are driving the UK viral clearance market?

Applications include Blood and Blood Products, Recombinant Proteins, and Vaccines. Read More

Q: Which end-users are contributing to the UK viral clearance market?

End-users include the Pharmaceutical and Biotech Industry, Academic Research Institutes, and CROs. Read More

ID: MRFR/HC/50367-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

UK Viral Clearance Market Research Report By Method (Viral Removal Method, Viral Inactivation Method, Viral Detection Method), By Application (Blood and Blood Products, Recombinant Proteins, Cellular and amp Gene Therapy Products, Vaccines, Others) and By End-user (Pharmaceutical and Biotech Industry, Academic Research Institutes, CROs, Others) - Growth & Industry Forecast 2025 To 2035

UK Viral Clearance Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)22.0%

2024 Market Size$ 44 Million

2025 Market Size$ 53.68 Million

2035 Market Size$ 392.18 Million

Key Players

Sartorius

Merck KGaA

Thermo Fisher Scientific

Charles River Laboratories

Lonza Group

Boehringer Ingelheim

Trends

Technological Advancements
Regulatory Compliance
Collaborative Research Initiatives

Opportunities

Stringent Regulatory Frameworks
Increased Focus on Patient Safety
Growing Investment in Biotechnology

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Method (USD Million)
  1. 4.1.1 Viral Removal Method
  2. 4.1.2 Viral Inactivation Method
  3. 4.1.3 Viral Detection Method
2. 4.2 Pharmaceutical, BY Application (USD Million)
  1. 4.2.1 Blood and Blood Products
  2. 4.2.2 Recombinant Proteins
  3. 4.2.3 Cellular & Gene Therapy Products
  4. 4.2.4 Vaccines
  5. 4.2.5 Others
3. 4.3 Pharmaceutical, BY End-user (USD Million)
  1. 4.3.1 Pharmaceutical and Biotech Industry
  2. 4.3.2 Academic Research Institutes
  3. 4.3.3 CROs
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Sartorius (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck KGaA (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Charles River Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Lonza Group (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Boehringer Ingelheim (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Fujifilm Diosynth Biotechnologies (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 KBI Biopharma (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 WuXi AppTec (CN)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY METHOD
3. 6.3 UK MARKET ANALYSIS BY APPLICATION
4. 6.4 UK MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
11. 6.11 PHARMACEUTICAL, BY METHOD, 2024 (% SHARE)
12. 6.12 PHARMACEUTICAL, BY METHOD, 2024 TO 2035 (USD Million)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
16. 6.16 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY METHOD, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Pharmaceutical Market Segmentation

Pharmaceutical By Method (USD Million, 2025-2035)

Viral Removal Method
Viral Inactivation Method
Viral Detection Method

Pharmaceutical By Application (USD Million, 2025-2035)

Blood and Blood Products
Recombinant Proteins
Cellular & Gene Therapy Products
Vaccines
Others

Pharmaceutical By End-user (USD Million, 2025-2035)

Pharmaceutical and Biotech Industry
Academic Research Institutes
CROs
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”